A síndrome de Legg-Calvé-Perthes ou doença de Perthes é uma doença degenerativa da articulação da anca (quadril em português brasileiro) em que ocorre. El absceso del psoas es una enfermedad infrecuente en niños. Puede tener una en pediatría es primario; sin embargo, en ocasiones, puede ser de origen secundario y médula espinal, enfermedad de. Legg-Calvé-Perthes, entre otros Download Citation on ResearchGate | Enfermedad de Legg Calvé Perthes (LCP) en varios aspectos de la enfermedad de Legg Calvé Perthes y la evolución de caderas de August · Anales espanoles de pediatria.
|Published (Last):||3 December 2016|
|PDF File Size:||7.63 Mb|
|ePub File Size:||16.60 Mb|
|Price:||Free* [*Free Regsitration Required]|
Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a perthse content of an inhibitor in the fibrinolytic system. Decreased fibrynolitic potential in patients with idio-pathic avascular necrosis and transient osteoporosis of the hip.
Blood, perthsepp. Association of antithrombotic factor deficiencies and hy-pofibrinolysis with Legg-Perthes disease. Resistance to activated protein C and Legg-Perthes disease. Special laboratory evaluation of coagulation.
Blood, 80pp. Lancet,pp. J Clin Invest, 94pp.
Determination of plasminogen activator and its fast inhibitor in plasma. Blood, 85pp. The second international anticardiolipin standardization workshop.
J Biol Chem,pp. J Lab Clin Med,pp. J Med,pp. Association of idiopathic venous thromboembolism with single point-mutation at Arg of factor. Thromb Haemost, 69pp. Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high Lp aand therapy with stanozolol. Thromb Haemost, 78pp. Mutation in gene coding for factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med,pp.
The remaining patients were considered withinthe normal range when age was taken into account. Pediatr Res, 35pp. Nature,pp. Anal Biochem,pp.
Enfermedad de Legg-Calve-Perthes
Am J Hematol, 44pp. It has been suggested that the cause of Perthes diseasemay be intravascular thrombosis induced by a potentialcongenital hemostatic disorder leading to conditions ofthrombophilia or hyperfibrinolysis. Genetics aspects of Perthes disease: Blood, 87pp. Am J Clin Pathol, 94pp.
Síndrome de Legg-Calvé-Perthes – Wikipédia, a enciclopédia livre
Activated protein C resistance as an additional risk factor for thrombosis in protein C deficient families. Continuing navigation will be considered as acceptance of this use. Complete study of hemostasis with coagulation and antithrombinfactors as well as study of thrombophilia prthes in these patients could determine the prevalenceof hemostasis and fibrinolysis in this group of patients.
To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. Pediqtria Epidemiological enfermsdad laboratory data from this group ofpediatric patients and from the control group do not supportthe hypothesis that a thrombogenesis defect couldbe the underlying cause of avascular necrosis of the hipjoint.
The remaining patients were considered withinthe normal range when age was taken into account. Thromb Haemost, 62pp. Perthes’ disease and the relevance of thrombophilia.
Thromb Res, 11pp. Changes in coagulation-fibrinolysis system in Legg-Perthes disease: Protein C and S deficiency, thrombofilia and hypofibrinolysis: Non enfrrmedad osteonecrosis of the femoral head: Am J Hematol, 45pp. Aguirre Canyadell aI. Espectrophotometric solid-phase tissue plasminogen activator activity assay Sofia-tPA for high-fibrin-affinity tissue plasminogen activators.
Are you a health professional able pediateia prescribe or dispense drugs? Background It has been suggested that the cause of Perthes diseasemay be intravascular thrombosis induced by a potentialcongenital hemostatic disorder leading to conditions ofthrombophilia or hyperfibrinolysis.
Maturation of the hemostatic system during childhood. The Kinston antiphospholipid group. You can change the settings or obtain more information by clicking here.
J Pediatr Orthop, 19pp.
Identification of the same factor V gene mutation in 47 of 50 thrombosis-prone families with inherited resistance to activated protein C. Variability of thrombosis among homozigous siblings with resistance to activated protein C due to an Arg-Gln mutaion in gen for factor V. Anticoagulant protein C pathway defective in majority of thromboembolic patients. Patients and method Complete study of hemostasis with coagulation and antithrombinfactors as well as study of thrombophilia andfibrinolysis in these patients could determine the prevalenceof hemostasis and fibrinolysis in this group of patients.